vimarsana.com

Page 9 - தேசிய மையம் க்கு தொற்று நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19: People allergic to first dose of mRNA vaccine to be counted as fully vaccinated if second jab is Sinovac, says Singapore minister | Singapore

Tuesday, 03 Aug 2021 07:33 AM MYT The Sinovac Covid-19 vaccine being used by a healthcare worker in Indonesia. AFP pic Follow us on Instagram and subscribe to our Telegram channel for the latest updates. SINGAPORE, Aug 3 People with an allergic reaction to the first dose of the approved Pfizer-BioNTech or Moderna Covid-19 vaccines are being invited to complete their vaccination process with the China-made Sinovac vaccine. Those who do so will be counted as fully vaccinated. They may also choose to wait for the United States-developed Novavax vaccine, which is expected to arrive by the end of the year, but it is unclear at this point if the authorities are able to consider those who may complete their vaccination with it fully vaccinated as well.

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant

Study shows efficacy of Pfizer-BioNTech and Moderna vaccines against SARS-CoV-2 delta variant Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The team conducted a multi-center retrospective cohort study of vaccinated and unvaccinated individuals who had been admitted to hospital following infection with the B.1.617.2 variant of concern. “To our knowledge, we provide the first data characterizing the impact of vaccination on virologic kinetics by the B.1.617.2 variant,” writes Barnaby Young from the National Centre for Infectious Diseases in Singapore and colleagues.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.